ArticleDrug design, development and therapy2016

Comparison of cisplatinum/paclitaxel with cisplatinum/5-fluorouracil as first-line therapy for nonsurgical locally advanced esophageal squamous cell carcinoma patients.

Guofang Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.